(Q47821289)

5 February 2018

title

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. (English)

1 reference

5 February 2018

secondary progressive multiple sclerosis

main subject

0 references

0 references

0 references

Maja Eriksson

1

1 reference

5 February 2018

Oluf Andersen

series ordinal

2

1 reference

5 February 2018

Björn Runmarker

series ordinal

3

1 reference

5 February 2018

publication date

1 June 2003

1 reference

5 February 2018

Multiple Sclerosis Journal

published in

1 reference

5 February 2018

volume

9

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

260-274

1 reference

5 February 2018

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Disability rating scales in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

HLA and prognosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

The natural history of multiple sclerosis: implications for trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS914OA

10.1191/1352458503MS914OA

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018